Tariff uncertainty continues market volatility
Wall Street extends slide sparked by fears over Donald Trump's on-off trade war ...
Editor and stylist Mel Ottenberg: 'I don't look good in fashion'
The editor-in-chief of Interview loves blue shampoo, double denim and his black leather de Sede couch ...
'It's like a whipsaw': Donald Trump's tariff U-turns unnerve businesses and investors
President's erratic policymaking has caused 'a lot of uncertainty' across corporate America ...
Troubled ex-spyware fund braces for €125mn hit from soured Romanian deal
Fund raised by Novalpina Capital which backed NSO Group preparing for 'significant loss' on gambling investment ...
How much Bitcoin does the US hold, and where did it come from?
The US Strategic Bitcoin Reserve will initially be funded by Bitcoin forfeited to the Treasury, which controls an estimated 198,109 Bitcoin forfeited or seized in criminal cases.
Roche announces launch of Roche Genentech Innovation Center Boston based at Harvard's Enterprise Research Campus in Allston
Basel, March 7, 2025 - Roche ( SIX: RO, ROG. OTCQX: RHHBY ) , announced today the launch of the Roche Genentech Innovation Center Boston at Harvard's Enterprise Research Campus in Allston which will further strengthen the long-standing partnership in areas such as disease biology, engineering, ...
argenx Highlights FcRn Leadership with Long-term Data and Transformational Patient Outcomes at the American Academy of Neurology 2025 Annual Meeting - argenx ( NASDAQ:ARGX )
Largest safety data set on FcRn blocking demonstrates consistent, favorable safety profile of VYVGART and VYVGART Hytrulo gMG patients on VYVGART achieve rapid, substantial, and sustained efficacy across multiple dosing regimens, supporting individualized treatment approach
argenx Highlights FcRn Leadership with Long-term Data and Transformational Patient Outcomes at the American Academy of Neurology 2025 Annual Meeting
Amsterdam, the Netherlands - March 7, 2025 - argenx SE ( Euronext & Nasdaq: ARGX ) , a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced clinical trial and real-world data for VYVGART® ( efgartigimod alfa-fcab ) and ...
SPIE - 2025 Investor Day - Press release
Cergy, March 7th 2025 - SPIE, the independent European leader in multi-technical services in the areas of energy and communications, is hosting its 2025 Investor Day today at 9 am CET. At this event, SPIE's management team will provide an in-depth look at the Group's strategy and value creation ...
Reminder of expiration of the offer period in the recommended voluntary cash offer to acquire all issued and outstanding shares of Belships ASA
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, INTO OR WITHIN CANADA, AUSTRALIA, NEW ZEALAND, SOUTH AFRICA, JAPAN, HONG KONG, SOUTH KOREA, OR ANY JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.
